Name: OnKure Therapeutics, Inc. (OKUR) Financial Statements
Creator: FinSpry

OnKure Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

OnKure Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	43.80	32.12	25.86	28.17
Selling, General & Administrative	10.59	4.82	3.90	11.65
Operating Expenses	54.39	36.93	29.77	39.82
Operating Income	-54.39	-36.93	-29.77	-39.82
Other Income/Expense
Interest Income	2.01	1.62	0.25	0.00
Interest Expense	0.30	0.00	0.00	0.00
Other Income/Expense	-0.04	-5.67	1.89	-0.05
Income
Income Before Tax	-52.67	-35.31	-29.51	-39.77
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-52.67	-35.31	-29.51	-39.77
Net Income - Continuous Operations	-52.67	-35.31	-29.51	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-51.71	-36.52	-29.38	-39.52
EBIT	-52.37	-36.93	-29.77	-39.77
Depreciation & Amortization	0.66	0.42	0.39	0.00
Earnings Per Share
Basic EPS	-15.00	-124.00	-2.00	-2.00
Diluted EPS	-15.00	-124.00	-2.00	-2.00
Basic Shares Outstanding	3.45	0.28	13.34	18.14
Diluted Shares Outstanding	3.45	0.28	13.34	18.14